- You are here: Home
- Distributors
- Animal Tumor Models
About Us
-
Cell Services
- Cell Line Authentication
- Cell Surface Marker Validation Service
-
Cell Line Testing and Assays
- Toxicology Assay
- Drug-Resistant Cell Models
- Cell Viability Assays
- Cell Proliferation Assays
- Cell Migration Assays
- Soft Agar Colony Formation Assay Service
- SRB Assay
- Cell Apoptosis Assays
- Cell Cycle Assays
- Cell Angiogenesis Assays
- DNA/RNA Extraction
- Custom Cell & Tissue Lysate Service
- Cellular Phosphorylation Assays
- Stability Testing
- Sterility Testing
- Endotoxin Detection and Removal
- Phagocytosis Assays
- Cell-Based Screening and Profiling Services
- 3D-Based Services
- Custom Cell Services
- Cell-based LNP Evaluation
-
Stem Cell Research
- iPSC Generation
- iPSC Characterization
-
iPSC Differentiation
- Neural Stem Cells Differentiation Service from iPSC
- Astrocyte Differentiation Service from iPSC
- Retinal Pigment Epithelium (RPE) Differentiation Service from iPSC
- Cardiomyocyte Differentiation Service from iPSC
- T Cell, NK Cell Differentiation Service from iPSC
- Hepatocyte Differentiation Service from iPSC
- Beta Cell Differentiation Service from iPSC
- Brain Organoid Differentiation Service from iPSC
- Cardiac Organoid Differentiation Service from iPSC
- Kidney Organoid Differentiation Service from iPSC
- GABAnergic Neuron Differentiation Service from iPSC
- Undifferentiated iPSC Detection
- iPSC Gene Editing
- iPSC Expanding Service
- MSC Services
- Stem Cell Assay Development and Screening
- Cell Immortalization
-
ISH/FISH Services
- In Situ Hybridization (ISH) & RNAscope Service
- Fluorescent In Situ Hybridization
- FISH Probe Design, Synthesis and Testing Service
-
FISH Applications
- Multicolor FISH (M-FISH) Analysis
- Chromosome Analysis of ES and iPS Cells
- RNA FISH in Plant Service
- Mouse Model and PDX Analysis (FISH)
- Cell Transplantation Analysis (FISH)
- In Situ Detection of CAR-T Cells & Oncolytic Viruses
- CAR-T/CAR-NK Target Assessment Service (ISH)
- ImmunoFISH Analysis (FISH+IHC)
- Splice Variant Analysis (FISH)
- Telomere Length Analysis (Q-FISH)
- Telomere Length Analysis (qPCR assay)
- FISH Analysis of Microorganisms
- Neoplasms FISH Analysis
- CARD-FISH for Environmental Microorganisms (FISH)
- FISH Quality Control Services
- QuantiGene Plex Assay
- Circulating Tumor Cell (CTC) FISH
- mtRNA Analysis (FISH)
- In Situ Detection of Chemokines/Cytokines
- In Situ Detection of Virus
- Transgene Mapping (FISH)
- Transgene Mapping (Locus Amplification & Sequencing)
- Stable Cell Line Genetic Stability Testing
- Genetic Stability Testing (Locus Amplification & Sequencing + ddPCR)
- Clonality Analysis Service (FISH)
- Karyotyping (G-banded) Service
- Animal Chromosome Analysis (G-banded) Service
- AAV Biodistribution Analysis (RNA ISH)
- Molecular Karyotyping (aCGH)
- Droplet Digital PCR (ddPCR) Service
- Digital ISH Image Quantification and Statistical Analysis
- SCE (Sister Chromatid Exchange) Analysis
- Biosample Services
- Histology Services
- Exosome Research Services
- In Vitro DMPK Services
-
In Vivo DMPK Services
- Pharmacokinetic and Toxicokinetic
- PK/PD Biomarker Analysis
- Bioavailability and Bioequivalence
- Bioanalytical Package
- Metabolite Profiling and Identification
- In Vivo Toxicity Study
- Mass Balance, Excretion and Expired Air Collection
- Administration Routes and Biofluid Sampling
- Quantitative Tissue Distribution
- Target Tissue Exposure
- In Vivo Blood-Brain-Barrier Assay
- Drug Toxicity Services
Animal Tumor Models
One of the recognized deficiencies in the field of cancer research is a lack of model systems that allow investigation of the carcinogenesis and cancer therapy. To evaluate the efficacy of cancer treatments in preclinical and clinical studies, animal tumor models whereby human cell lines or patient derived tumors are transplanted into immunocompromised mice are commonly used. Animal tumor models provide a close alternative to clinical testing and allow researchers to understand the mechanisms of clinical drug action, which is critical before taking a drug candidate to clinical trials.
Creative Bioarray provides diverse animal tumor models that being research hotspots at present, which includes the following categories, but is not limited to:
Cancer cell line-based xenograft (CDX) model
Creative Bioarray maintains various human tumor cell lines that are invaluable for medical, scientific and pharmaceutical institutions. In the meantime, Creative Bioarray supplies several types of quality certificated immunodeficient mice including nude mice, severely compromised immune deficient (SCID) mice, and SCID mice with nonobese diabetic (NOD-SCID) to assisting customers to get access to exquisite animal models.
Patient-derived tumor xenograft (PDX) model
Patient-derived tumor xenografts (PDX) are based on the transfer of primary tumors directly from the patient into an immunodeficient mouse. This modeling pattern can avoid harsh chemical or mechanical injury that may sensitize cells to anoikis and thereby improve the engraftment rate from 60% up to 95%. Because PDX mice are derived from human tumors, they offer a tool for developing anticancer therapies and personalized medicine for patients with cancer. Services in Creative Bioarray are including but not limited to PDX model creation, technical support of transplantation as well as comprehensive histopathological analysis.
Humanized-xenograft model
Humanized-xenograft models are created by co-engrafting the patient tumor fragment and peripheral blood or bone marrow cells into NOD-SCID mice. The pattern allows for reconstitution of the murine immune system enabling researchers to study the interactions between tumor environments and xenogenic tumor stroma in cancer progression and metastasis.
Allograft model
Allograft models are comprised of allografts of spontaneous murine tumors derived from GEMM or carcinogen-induced models. This kind of models are never manipulated or adapted to grow in vitro, mirroring original mouse tumor histopathology and genetic profiles, with different differentiation phenotypes, rich microenvironments, and cancer stem cell driven disease.
Syngeneic tumor model
Creative Bioarray provides a number of well validated syngeneic tumor models for preclinical immunotherapy research. Syngeneic tumor models are allografts derived from immortalized mouse cancer cell lines which originated from the same inbred strain of mice. By using the models, researchers can assess new single agent and combination immunotherapies within mice with fully competent immunity.
Advantages
Creative Bioarray is dedicated to establish the most competitive service platforms for Oncology research. Our scientific staff can assist you at each single step from model selection, model construction, drug efficacy testing to the study on characterization and biomarker validation, aiming to create effective pre-clinical investigation by reasonable resource utilization as well as exquisite biomedical attainments.
Quotation and Order
If you have any special needs in establishment or application of animal tumor models, please contact us for this special service. Let us know what you need and we will accommodate you. We look forward to working with you in the future.
References
- Yuzhuo W,; Daniel S, et al. A Human Prostatic Epithelial Model of Hormonal Carcinogenesis. Cancer Res. 2001, 61: 6064-6072.
- Despina S,; Gregory JH. Patient-Derived Tumor Xenografts: Transforming Clinical Samples into Mouse Models. Cancer Res. 2013, 73(17): 5315-5319.
For research use only. Not for any other purpose.